1.Klein, JO, Feigin, RD, McCracken, GH. Report on the task force on diagnosis and management of meningitis. Pediatrics 1986; 78: 959–82.
2.Philip, AGS. Neonatal Sepsis and Meningitis. Boston: G.K. Hall, 1985: Appendix.
3.Philip, AGS. The changing face of neonatal infection: experience at a regional medical center. Pediatr Infect Dis J 1994; 13: 1098–102.
4.Greenberg, D, Shinwell, ES, Yagupsky, P, et al. A prospective study of neonatal sepsis and meningitis in southern Israel. Pediatr Infect Dis J 1997; 16: 768–73.
5.Moreno, MT, Vargas, S, Poveda, R, et al. Neonatal sepsis and meningitis in a developing Latin American country. Pediatr Infect Dis J 1994; 13: 516–20.
6.Laving, AM, Musoke, RN, Wasunno, AO, et al. Neonatal bacterial meningitis at the newborn unit of Kenyatta National Hospital. East Afr Med J 2003; 80: 456–62.
7.Trijbels-Smeulders, M, de Jonge, GA, Pasker-de Jonge, PC, et al. Epidemiology of neonatal group B streptococcal disease in the Netherlands before and after introduction of guidelines for prevention. Arch Dis Child Fetal Neonatal Ed 2007; 92: F271–6.
8.Mulder, CJJ, Zanen, HC. A study of 280 cases of neonatal meningitis in the Netherlands. J Infect 1984; 9: 177–84.
9.De Louvois, J, Halket, S, Harvey, D. Neonatal meningitis in England and Wales: sequelae at 5 years of age. Eur J Pediatr 2005; 164: 730–4.
10.Isaacs, D, Royle, JA. Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia. Australasian Study Group for Neonatal Infections. Pediatr Infect Dis J 1999; 18: 524–8.
11.Francis, BM, Gilbert, GL. Survey of neonatal meningitis in Australia:1987–1989. Med J Aust 1992; 156: 240–3.
12.Gordon, A, Isaacs, D. Late onset neonatal gram-negative bacillary infection in Australia and New Zealand, 1992–2002. Pediatr Infect Dis J 2006; 25: 25–9.
13.Schrag, SJ, Stoll, BJ. Early-onset neonatal sepsis in the era of widespread intrapartum chemoprophylaxis. Pediatr Infect Dis J 2006; 25: 939–40.
14.May, M, Daley, AJ, Donarth, S, et al. Early onset neonatal meningitis in Australia and New Zealand, 1992–2002. Arch Dis Child Fetal Neonatal Ed 2005; 90: F324–7.
14a.Okike, IO, Johnson, AP, Henderson, KL, et al. Incidence, etiology and outcome of bacterial meningitis in infants aged <90 days in the United Kingdom and the Republic of Ireland: prospective, enhanced national population-based surveillance. Clin Infect Dis 2014; 59: e150–7.
14b.Darlow, BA, Voss, L, Lennon, DR, Grimwood, K. Early-onset neonatal group B Streptococcus sepsis following national risk-based prevention guidelines. Austr NZ Obstet Gynaecol 2016; 56: 60–74.
15.Longe, AC, Omene, JA, Okolo, AA. Neonatal meningitis in Nigerian infants. Acta Paediatr Scand 1984; 73: 477–81.
16.Tessin, I, Trollfors, B, Thiringer, K. Incidence and etiology of neonatal septicemia and meningitis in western Sweden 1975–1986. Acta Paediatr Scand 1990; 79: 1023–30.
17.Hristeva, L, Booy, R, Bowler, I, et al. Prospective surveillance of neonatal meningitis. Arch Dis Child 1993; 69: 14–18.
18.Shiva, F, Mosaffa, N, Khabbaz, R, et al. Lumbar puncture in neonates under and over 72 hours of age. J Coll Phys Surg Pak 2006; 16: 525–8.
19.Weiss, MG, Ionides, SP, Anderson, CL. Meningitis in premature infants with respiratory distress: role of admission lumbar puncture. J Pediatr 1991; 119: 973–5.
20.Sanghvi, KP, Tudehope, DI. Neonatal bacterial sepsis in a neonatal intensive care unit: a 5 year analysis. J Paediatr Child Health 1996; 32: 333–8.
21.Johnson, CE, Whitwell, JK, Pethe, K, et al. Term newborns who are at risk for sepsis: are lumbar punctures necessary? Pediatrics 1997; 99: E10.
22.Pong, A, Bradley, JS. Bacterial meningitis and the newborn infant. Infect Dis Clin North Am 1999; 13: 711–33.
23.Albanyan, EA, Baker, CJ. Is lumbar puncture necessary to exclude meningitis in neonates and young infants: lessons from the group B Streptococcus cellulitis-adenitis syndrome. Pediatrics 1998; 102: 985–6.
23a.Flidel-Rimon, O, Leibovitz, E, Eventor Friedman, S, et al: Is lumbar puncture (LP) required in every work-up for suspected late-onset sepsis in neonates? Acta Paediatr 2011; 100: 303–4.
24.Stoll, BJ, Hansen, N, Fanaroff, AA, et al. To tap or not to tap:high likelihood of meningitis without sepsis among very low birth weight infants. Pediatrics 2004; 113: 1181–6.
25.Franco, SM, Cornelius, VE, Andrews, BF. Long-term outcome of neonatal meningitis. Am J Dis Child 1992; 146: 567–71.
26.Unhanand, M, Mustafa, MM, McCracken, GH Jr, et al. Gram-negative enteric bacillary meningitis: a twenty-one-year experience. J Pediatr 1993; 122: 15–21.
27.Edwards, MS, Rench, MA, Haffar, AAM, et al. Long-term sequelae of group B streptococcal meningitis in infants. J Pediatr 1985; 106: 717–22.
28.Klinger, G, Chin, CN, Beyene, J, et al. Predicting the outcome of neonatal bacterial meningitis. Pediatrics 2000; 106: 477–82.
29.Dellagrammaticas, HD, Christodoulou, C, Megaloyanni, E, et al. Treatment of gram-negative bacterial meningitis in term neonates with third generation cephalosporins plus amikacin. Biol Neonate 2000; 77: 139–46.
30.Harvey, D, Holt, DE, Bedford, H. Bacterial meningitis in the newborn: a prospective study of mortality and morbidity. Semin Perinatol 1999; 23: 218–25.
31.Chang, CJ, Chang, WN, Huang, LT, et al. Neonatal bacterial meningitis in southern Taiwan. Pediatr Neurol 2003; 29: 288–94.
32.Daoud, AS, al-Sheyyab, M, Abu-Ekteish, F, et al. Neonatal meningitis in northern Jordan. J Trop Pediatr 1996; 42: 267–70.
33.Molyneux, E, Walsh, A, Phiri, A, et al. Acute bacterial meningitis in children admitted to the Queen Elizabeth Central Hospital, Blantyre, Malawi in 1996–97. Trop Med Int Health 1998; 3: 610–18.
33a.Kamoun, F, Dowlut, MB, Ameur, SB, et al. Neonatal purulent meningitis in southern Tunisia: Epidemiology, bacteriology, risk factors and prognosis. Fetal Pediatr Pathol 2015; 34: 233–40.
33b.Gaschignard, J, Levy, O, Olivier, R, et al. Neonatal bacterial meningitis: 444 cases in 7 years. Pediatr Infect Dis J 2011; 30: 212–17.
33c.Thigpen, MC, Whitney, CG, Massonnier, NE, et al. Bacterial meningitis in the United States, 1998–2007. N Engl J Med 2011; 364: 2016–25.
34.Synnott, MB, Morse, DL, Hall, SM. Neonatal meningitis in England and Wales: a review of routine national data. Arch Dis Child 1994; 71: F75–80.
35.Gebremariam, A. Neonatal meningitis in Addis Ababa: a 10 year review. Ann Trop Paediatr 1998; 18: 279–83.
36.Berardi, A, Lugli, L, Baronciani, D, et al. Group B streptococcal infections in a northern region of Italy. Pediatrics 2007; 120: e487–93.
37.Mulder, CJJ, Zanen, HC. Listeria monocytogenes neonatal meningitis in the Netherlands. Eur J Pediatr 1986; 145: 60–2.
38.Linnan, MJ, Mascola, L, Lou, XD, et al. Epidemic listeriosis associated with Mexican-style cheese. N Engl J Med 1988; 319: 823–8.
39.Zaki, M, Daoud, AS, al Saleh, Q, et al. Bacterial meningitis in the newborn: a Kuwaiti experience. J Trop Pediatr 1990; 36: 62–5.
40.Baker, CJ. Group B streptococcal infections in neonates. Pediatr Rev 1979; 1: 5–15.
41.Carstensen, H, Henrichsen, J, Jepsen, OB. A national survey of severe group B streptococcal infections in neonates and young infants in Denmark, 1978–83. Acta Paediatr Scand 1985; 74: 934–41.
41a.Joubrel, C, Tazi, A. Six, A, et al. Group B Streptococcus neonatal invasive infections, France 2007–2012. Clin Microbiol Infect 2015; 21: 910–16.
42.Domelier, AS, van der Mee-Marquet, N, Grandet, A, et al. Loss of catabolic function in Streptococcus agalactiae strains and its association with neonatal meningitis. J Clin Microbiol 2006; 44: 3245–50.
42a.Brandolini, M, Corbella, M, Cambieri, P, et al. Late-onset neonatal group B streptococcal disease associated with breast-milk transmission: molecular typing using RAPD-PCR. Early Hum Dev 2014; 90(Suppl 1): S84–6.
43.Mulder, CJJ, van Alphen, L, Zanen, HC. Neonatal meningitis caused by Escherichia coli in the Netherlands. J Infect Dis 1984; 150: 935–40.
43a.Basmaci, R, Bonacorsi, S, Bidot, P, et al. Escherichia coli meningitis features in 325 children from 2001 to 2013 in France. Clin Infect Dis 2015; 61: 779–86.
44.Ignjatovic, M. Bacterial causes of meningitis in newborns [in Serbian]. Srp Arh Calok Lek 2001; 129: 36–41.
45.Davies, PA, Rudd, PT. Neonatal Meningitis (Clinics in Developmental Medicine 132). London: MacKeith Press, 1994.
46.Arango, CA, Rathore, MH. Neonatal meningococcal meningitis: case reports and review of literature. Pediatr Infect Dis J 1996; 15: 1134–6.
47.Doctor, BA, Newman, N, Minich, NM, et al. Clinical outcomes of neonatal meningitis in very low-birth-weight infants. Clin Pediatr 2001; 40: 473–80.
48.Tse, G, Silver, M, Whyte, H, et al. Neonatal meningitis and multiple brain abscesses due to Citrobacter diversus. Pediatr Pathol Lab Med 1997; 17: 977–82.
49.Goldenberg, RL, Hauth, JC, Andrews, WW. Intrauterine infection and preterm delivery. N Engl J Med 2000; 342: 1500–7.
50.Edwards, MS, Jackson, CV, Baker, CJ. Increased risk of group B streptococcal disease in twins. JAMA 1981; 245: 2044–6.
51.Levy, HL, Sepe, SJ, Shih, VE, et al. Sepsis due to Escherichia coli in neonates with galactosemia. N Engl J Med 1977; 297: 823–5.
52.Bingen, E, Bonacorsi, S, Brahimi, N, et al. Virulence patterns of Escherichia coli K1 strains associated with neonatal meningitis. J Clin Microbiol 1997; 35: 2981–2.
53.Öhman, L, Tullus, K, Katouli, M, et al. Correlation between susceptibility of infants to infection and interaction with neurotrophils of Escherichia coli strains, causing neonatal and infantile septicemia. J Infect Dis 1995; 171: 128–33.
54.Berman, P, Banker, B. Neonatal meningitis:a clinical and pathological study of 29 cases. Pediatrics 1966; 38: 6–24.
55.Bell, WE, McGuinness, GA. Suppurative central nervous system infections in the neonate. Semin Perinatol 1982; 6: 1–24.
56.Polin, RA, Harris, MC. Neonatal bacterial meningitis. Semin Neonatol 2001; 6: 157–72.
57.Anagnostakis, D, Messaritakis, J, Damianos, D, et al. Blood-brain barrier permeability in “healthy,” infected and stressed neonates. J Pediatr 1992; 121: 291–4.
58.Temesvari, P, Abraham, CS, Speer, CP, et al. Escherichia coli O111 B4 lipopolysaccharide given intracisternally induces blood-brain barrier opening during experimental neonatal meningitis in piglets. Pediatr Res 1993; 34: 182–6.
59.Huang, S, Stins, MF, Kim, KS. Bacterial penetration across the blood-brain barrier during the development of neonatal meningitis. Microbes Infect 2000; 2: 1237–44.
60.Chang Chien, HY, Chiu, NC, Li, WC, et al. Characteristics of neonatal bacterial meningitis in a teaching hospital in Taiwan from 1984–1997. J Microbiol Immunol Infect 2000; 33: 100–4.
61.Smith, PB, Cotton, CM, Garges, HP, et al. A comparison of neonatal gram-negative rod and gram-positive cocci meningitis. J Perinatol 2006; 26: 111–14.
62.Garges, HP, Moody, MA, Cotten, CM, et al. Neonatal meningitis:what is the correlation among cerebrospinal fluid cultures, blood cultures and cerebrospinal fluid parameters? Pediatrics 2006; 117: 1094–100.
63.Sarman, G, Moise, AA, Edwards, MS. Meningeal inflammation in neonatal gram-negative bacteremia. Pediatr Infect Dis J 1995; 14: 701–4.
64.Porter, FL, Miller, JP, Cole, FS, et al. A controlled clinical trial of local anesthesia for lumbar puncture in newborns. Pediatrics 1991; 88: 663–9.
65.Halcrow, SJ, Crawford, PJ, Craft, AW. Epidermoid spinal cord tumour after lumbar puncture. Arch Dis Child 1985; 60: 978–9.
66.McCracken, GH, Mize, SG. A controlled study of intrathecal antibiotic therapy in gram-negative enteric meningitis of infancy: report of the Neonatal Meningitis Co-operative Study Group. J Pediatr 1976; 89: 66–72.
67.Philip, AGS, Baker, CJ. Cerebrospinal fluid C-reactive protein in neonatal meningitis. J Pediatr 1983; 102: 715–17.
67a.Martinez de Tejada, B, Stan, CM, Boulvain, M, et al: Development of rapid PCR assay for screening maternal colonization by group B Streptococcus and neonatal invasive Escherichia coli during labor. Gynecol Obstet Invest 2010; 70: 250–5.
68.Philip, AGS. Response of C-reactive protein in neonatal group B streptococcal infection. Pediatr Infect Dis J 1985; 4: 145–8.
69.Sabel, KG, Hanson, LA. The clinical usefulness of C-reactive protein (CRP) determinations in bacterial meningitis and septicemia in infancy. Acta Paediatr Scand 1974; 63: 381–8.
70.Sabel, KG, Wadsworth, C. C-reactive protein (CRP) in early diagnosis of neonatal septicemia. Acta Paediatr Scand 1979; 68: 825–31.
71.Pourcyrous, M, Bada, HS, Korones, SB, et al. Significance of serial C-reactive protein responses in neonatal infection and other disorders. Pediatrics 1993; 92: 431–5.
72.Andersen, J, Christensen, R, Hartel, J. Clinical features and epidemiology of septicemia and meningitis in neonates due to Streptococcus agalactiae in Copenhagen County, Denmark: a 10 year survey from 1992 to 2001. Acta Paediatr 2004; 93: 1334–9.
73.Putto, A, Ruuskanen, O, Meurman, O, et al. C-reactive protein in the evaluation of febrile illness. Arch Dis Child 1986; 61: 24–9.
74.Raju, VSN, Rao, MN, Rao, VSRM. Cranial sonography in pyogenic meningitis in neonates and infants. J Trop Pediatr 1995; 41: 68–73.
75.Hill, A, Shackelford, GD, Volpe, JJ. Ventriculitis with neonatal bacterial meningitis: identification by real-time ultrasound. J Pediatr 1981; 99: 133–6.
76.Trivedi, R, Malik, GK, Gupta, RK, et al. Increased anisotropy in neonatal meningitis: an indicator of meningeal inflammation. Neuroradiology 2007; 49: 767–75.
76a.Tibussek, D. Sinclair, A. Yau, I, et al: Late-onset group B streptococcal meningitis has cerebrovascular complications. J Pediatr 2015; 166: 1187–92.
77.Vogel, LC, Boyer, KM, Gadzala, CA, et al. Prevalence of type-specific group B streptococcal antibody in pregnant women. J Pediatr 1980; 96: 1047–51.
78.Sidiropoulos, D, Hermann, U, Morell, A, et al. Transplacental passage of intravenous immunoglobulin in the last trimester of pregnancy. J Pediatr 1986; 109: 505–8.
79.Edwards, MS, Hall, MA, Rench, MA, et al. Patterns of immune response among survivors of group B streptococcal meningitis. J Infect Dis 1990; 161: 65–70.
80.Baker, CJ, Rench, MA, Edwards, MS, et al. Immunization of pregnant women with a polysaccharide vaccine of group B Streptococcus. N Engl J Med 1988; 319: 1180–5.
81.Sennhauser, FH, Balloch, A, MacDonald, RA, et al. Materno-fetal transfer of IgG anti-Escherichia coli antibodies with enhanced avidity and opsonic activity in very premature neonates. Pediatr Res 1990; 27: 365–71.
82.Ment, LR, Ehrenkranz, RA, Duncan, CC. Bacterial meningitis as an etiology of perinatal cerebral infarction. Pediatr Neurol 1986; 2: 276–9.
83.Cohen, C, Rice, EN, Thomas, DE, et al. Diabetes insipidus as a hallmark neuroendocrine complication of neonatal meningitis. Curr Opin Pediatr 1998; 10: 449–52.
84.McCracken, GH, Mize, SG, Threlkeld, N. Intraventricular gentamicin therapy in gram-negative bacillary meningitis of infancy: report of the Second Neonatal Meningitis Co-operative Study Group. Lancet 1980; i: 787–91.
85.Renier, D, Flandin, C, Hirsch, E, et al. Brain abscesses in neonates: a study of 30 cases. J Neurosurg 1988; 69: 877–82.
86.Burdette, JH, Santos, C. Enterobacter sakazakii brain abscess in the neonate: the importance of neuroradiologic imaging. Pediatr Radiol 2000; 30: 33–4.
87.Isaacs, D. Unnatural selection: reducing antibiotic resistance in neonatal units. Arch Dis Child Fetal Neonatal Ed 2006; 91: F72–4.
88.Saez-Llorens, X, McCracken, GH. Antimicrobial and anti-inflammatory treatment of bacterial meningitis. Infect Dis Clin North Am 1999; 13: 619–36.
88a.Puopolo, K. Eichenwald, EC: No change in incidence of ampicillin-resistant neonatal early-onset sepsis over 18 years. Pediatrics 2010; 125: e1031–8.
89.Heath, PT, Nik Yussoff, NK, Baker, CJ. Neonatal meningitis. Arch Dis Child Fetal Neonatal Ed 2003; 88: F137–8.
90.Tessin, I, Trollfors, B, Thiringer, K, et al. Ampicillin-aminoglycoside combination as initial treatment for neonatal septicaemia or meningitis: a retrospective evaluation of 12 years experience. Acta Paediatr Scand 1991; 80: 911–16.
91.Adelman, RD, Wirth, F, Rubio, T. A controlled study of the nephrotoxicity of mezlocillin and gentamicin plus ampicillin in the neonate. J Pediatr 1987; 111: 888–93.
92.Tullus, K, Olsson-Liljequist, B, Lundstrom, G, et al. Antibiotic susceptibility of 629 bacterial blood and CSF isolates from Swedish infants and the therapeutic implications. Acta Paediatr Scand 1991; 80: 205–12.
93.Quinn, JP, Rodvold, KA. Antibiotic policies in neonatal intensive-care units. Lancet 2000; 355: 946–7.
94.Lebel, MH, Hoy, MJ, McCracken, GH. Comparative efficacy of ceftriaxone and cefuroxime for treatment of bacterial meningitis. J Pediatr 1989; 114: 1049–54.
95.Black, SB, Levine, P, Shinefield, HR. The necessity for monitoring chloramphenicol levels when treating neonatal meningitis. J Pediatr 1978; 92: 235–6.
96.Ahmed, A. A critical evaluation of vancomycin for treatment of bacterial meningitis. Pediatr Infect Dis J 1997; 16: 895–3.
97.Haimi-Cohen, Y, Amir, J, Weinstock, A, et al. The use of imipenem-cilastatin in neonatal meningitis caused by Citrobacter diversus. Acta Paediatr Int J Paediatr 1993; 82: 530–2.
98.Leggiadro, RJ. Favorable outcome possible in Citrobacter brain abscess. Pediatr Infect Dis J 1996; 15: 557.
99.Radetsky, M. Duration of treatment in bacterial meningitis: a historical inquiry. Pediatr Infect Dis J 1990; 9: 2–9.
100.Peltola, H, Luhtala, K, Valmari, P. C-reactive protein as a detector of organic complications during recovery from childhood purulent meningitis. J Pediatr 1984; 104: 869–72.
101.Astruc, J, Taillebois, L, Rodière, F, et al. Raccourcissement du traitment antibiotiques des méningites bactériennes de l’enfant:interêt de la surveillance de la C-réactive protéine. Arch Franc Pédiatr 1990; 47: 637–40.
101a.Mathur, NB Kharod, P, Kumar, S: Evaluation of duration of antibiotic therapy in neonatal bacterial meningitis: a randomized, controlled trial. J Trop Pediatr 2015; 61: 119–25.
102.Prober, CG. The role of steroids in the management of children with bacterial meningitis. Pediatrics 1995; 95: 29–31.
103.Daoud, AS, Batieha, A, Al-Sheyyab, M, et al. Lack of effectiveness of dexamethasone in neonatal bacterial meningitis. Eur J Pediatr 1999; 158: 230–3.
103a.Ogunlesi, TA. Odigwe, CC, Oladpo, OT. Adjuvant corticosteroids for reducing death in neonatal bacterial meningitis. Cochrane Database Syst Rev 2015; 11: CD010435.
104.McCracken, GH, Sarff, LD, Glode, MP, et al. Relation between Escherichia coli K1 capsular polysaccharide antigen and clinical outcome in neonatal meningitis. Lancet 1974; ii: 246–50.
104a.Levent, F, Baker, CJ, Rench, MA, Edwards, MS. Early outcomes of group B streptococcal meningitis in the 21st century. Pediatr Infect Dis J 2010; 29: 1009–12.
105.Bennet, R, Bergdahl, S, Eriksson, M, et al. The outcome of neonatal septicemia during fifteen years. Acta Paediatr Scand 1989; 78: 40–3.
106.Moffett, KS, Berkowitz, FE. Quadriplegia complicating Escherichia coli meningitis in a newborn infant: case report and review of 22 cases of spinal cord dysfunction in patients with acute bacterial meningitis. Clin Infect Dis 1997; 25: 211–14.
107.Klinger, G, Chin, CN, Otsobu, H, et al. Prognostic value of EEG in neonatal bacterial meningitis. Pediatr Neurol 2001; 24: 28–31.
108.Siegel, JD, McCracken, GH, Threlkeld, N, et al. Single-dose penicillin prophylaxis of neonatal group B streptococcal disease: conclusion of a 41 month controlled trial. Lancet 1982; i: 1426–30.
109.Pyati, SP, Pildes, RS, Jacobs, NM, et al. Penicillin in infants weighing two kilograms or less with early-onset group B streptococcal disease. N Engl J Med 1983; 308: 1383–9.
110.Baker, CJ, Melish, ME, Hall, RT, et al. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. N Engl J Med 1992; 327: 213–19.
111.Fanaroff, AA, Korones, SB, Wright, LL, et al. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 1994; 330: 1107–13.
112.Weisman, LE, Stoll, BJ, Kueser, TJ, et al. Intravenous immune globulin prophylaxis of late-onset sepsis in premature neonates. J Pediatr 1994; 125: 922–30.
113.Weisman, LE, Cruess, DF, Fischer, GW. Opsonic activity of commercially available standard intravenous immunoglobulin preparations. Pediatr Infect Dis J 1994; 13: 1122–5.
114.Boyer, KM, Gotoff, SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986; 314: 1665–9.
115.Ascher, DP, Becker, JA, Yoder, BA, et al. Failure of intrapartum antibiotics to prevent culture-proved neonatal group B streptococcal sepsis. J Perinatol 1992; 13: 212–16.
116.Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease:a public health perspective. MMWR Recomm Rep 1996; 45: 1–24.
117.Schrag, SJ, Zywicki, S, Farley, MM, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000; 342: 15–20.
118.Kalliola, S, Vuopio-Varkilla, J, Takala, AK, et al. Neonatal group B streptococcal disease in Finland:a ten-year nationwide study. Pediatr Infect Dis J 1999; 18: 806–10.
119.Puopolo, KM, Madoff, LC, Eichenwald, EC. Early-onset group B streptococcal disease in the era of maternal screening. Pediatrics 2005; 115: 1240–6.
120.Philip, AGS, Mills, PC. Use of C-reactive protein in minimizing antibiotic exposure: experience with infants initially admitted to a well-baby nursery. Pediatrics 2000; 106: e4.
121.Paoletti, LC, Madoff, LC. Vaccines to prevent neonatal GBS infection. Semin Neonatol 2002; 7: 315–23.
122.Baker, CJ, Paoletti, LC, Rench, MA, et al. Immune response of healthy women to two different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines. J Infect Dis 2004; 189: 1103–12.
122a.Baker, CJ, Carrey, VJ, Rench, MA, et al. Maternal antibody at delivery protects neonates from early-onset streptococcal disease. J Infect Dis 2014; 209: 781–8.
123.Bonadio, WA, Stanco, L, Bruce, R, et al. Reference values of normal cerebrospinal fluid composition in infants ages 0 to 8 weeks. Pediatr Infect Dis J 1992; 11: 589–91.
124.Ahmed, A, Hickey, SM, Ehrett, S, et al. Cerebrospinal fluid values in the term neonate. Pediatr Infect Dis J 1996; 15: 298–303.